News About: Pharm. Industry
Drugmakers fear possible fallout of Tylenol snafu
Domestic drug firms are now under full alert to inspect the manufacturing, product management and quality control procedures on their medicinal products as the quality control (QC) team of Janssen Korea was at the cen...
Hanmi picked as one of successful enterprises to lead global business
Hanmi Pharmaceutical Co. has been chosen as one of the nation’s successful businesses, along with other companies, to incessantly push ahead with global projects, Korea International Trade Association (KITA) said rece...
HIV drug delivery patch in the Pipeline, Samjin Pharm says
Samjin Pharmaceutical said Tuesday that its U.S. partner ImQuest Biosciences is developing a skin patch to deliver antiretroviral medications containing pyrimidinedione, citing a latter’s recent presentation at the 20...
Daewoong to export Easyef to TurkeyDaewoong has signed a signed a contract with a Turkish company to export its diabetic foot ulcer therapy called "Easyef" for the next five years, officials said Tuesday.
The...
|
Bayer rekindling strategic alliance flame
Bayer Korea is actively seeking strategic alliances with domestic pharmaceutical firms using its popular over-the-counter (OTC) products.
Bayer Korea has recently decided to transfer its OTC drugs, including Sarido...
Korean drug firms’ cash ratio falls in 2012
Korea's overall cash asset ratio deteriorated in 2012 from a year earlier due to the government’s forced price cut for drugs and other medical products covered by national health insurance, a local pharmaceutical port...
Domestic drug makers skimping on R&D investment
Despite their relatively large assets, the nation’s 50 Korean pharmaceutical companies spend considerably less on research and development (R&D), industry data showed recently.
Citing the data released by the Fina...
Biopharmatis to export CNS drugs to Hong Kong
Biopharmatis, an affiliate of Hyundai Pharmaceutical Co., said Tuesday that it has signed an agreement with a new partner of Hong Kong to export Hyundai’s CNS (central nervous system)-related two medicines, Multapin t...
BMS Korea keeps top spot in chronic hepatitis B market
BMS Korea, a Korean unit of Bristol Myers Squibb Company, maintained its dominant position in the domestic chronic hepatitis B market during the January-April period of the year, although its competitor Gilead Science...
Janssen Korea to face Tylenol production ban
Korea's food watchdog said last Thursday that that it would order to ban Janssen Korea from producing five drugs for five months while filing a criminal complaint with the prosecution against the head of Janssen Korea...
